Vickers Vantage Corp. I Contracts & Agreements

Deferral and Consent under Tranche B Senior Secured Convertible Note, dated January 2, 2025, by and among Scilex Holding Company, Nomis Bay Ltd, BPY Limited, SCLX Stock... (Filed With SEC on January 3, 2025)

Deferral and Consent under Tranche B Senior Secured Convertible Note, dated January 2, 2025, by and among Scilex Holding Company, Oramed Pharmaceuticals Inc., SCLX Stock... (Filed With SEC on January 3, 2025)

Deferral and Consent under Tranche B Senior Secured Convertible Note, dated January 2, 2025, by and among Scilex Holding Company, 3i, LP, SCLX Stock Acquisition JV LLC and Acquiom... (Filed With SEC on January 3, 2025)

Form of Pre-Funded Warrant (Filed With SEC on December 13, 2024)

Form of Common Warrant (Filed With SEC on December 13, 2024)

Form of StockBlock Warrant (Filed With SEC on December 13, 2024)

Amendment No. 1 to Common Stock Purchase Warrant., dated December 11, 2024, between Scilex Holding Company and the investor named therein (Filed With SEC on December 13, 2024)

Form of Securities Purchase Agreement, dated December 11, 2024, by and between the Company and the purchasers party thereto (Filed With SEC on December 13, 2024)

Waiver and Consent under Senior Secured Promissory Note, dated November 21, 2024, by and between Scilex Holding Company and Oramed Pharmaceuticals Inc (Filed With SEC on November 22, 2024)

Waiver and Consent to Securities Purchase Agreement and Tranche B Senior Secured Convertible Note, dated November 21, 2024, by and among Scilex Holding Company, Nomis Bay Ltd and... (Filed With SEC on November 22, 2024)

Waiver and Consent to Securities Purchase Agreement and Tranche B Senior Secured Convertible Note, dated November 21, 2024, by and between Scilex Holding Company and Oramed... (Filed With SEC on November 22, 2024)

Waiver and Consent to Securities Purchase Agreement and Tranche B Senior Secured Convertible Note, dated November 21, 2024, by and among Scilex Holding Company and 3i, LP (Filed With SEC on November 22, 2024)

Form of Tranche B Senior Secured Convertible Note issued by Scilex Holding Company (Filed With SEC on October 8, 2024)

Form of Warrant to Purchase Common Stock issued by Scilex Holding Company (Filed With SEC on October 8, 2024)

Form of Placement Agent Warrant issued by Scilex Holding Company (Filed With SEC on October 8, 2024)

Securities Purchase Agreement, dated October 7, 2024, by and between Scilex Holding Company and the investors signatory thereto (Filed With SEC on October 8, 2024)

Amendment No. 1 to Scilex-Oramed SPA, dated October 8, 2024, by and between Scilex Holding Company and Oramed Pharmaceuticals, Inc (Filed With SEC on October 8, 2024)

Purchase and Sale Agreement, dated October 8, 2024, by and among Scilex Holding Company, Silex Pharmaceuticals Inc. and the purchasers signatory thereto (Filed With SEC on October 8, 2024)

Security Agreement, dated October 8, 2024, by and among Scilex Pharmaceuticals Inc., and the purchasers signatory thereto (Filed With SEC on October 8, 2024)

Subordination Agreement, dated October 8, 2024, by and among Scilex Pharmaceuticals Inc., Acquiom Agency Services LLC and other signatories thereto (Filed With SEC on October 8, 2024)

Consent and Amendment, dated as of October 8, 2024, by and between Scilex Holding Company and Oramed Pharmaceuticals, Inc (Filed With SEC on October 8, 2024)

Subsidiary Guarantee Amendment, dated October 8, 2024, made by certain of the Company's subsidiaries in favor of the holders of that certain Tranche A Note (Filed With SEC on October 8, 2024)

Amended and Restated Security Agreement, dated October 8, 2024, by and among Scilex Holding Company, the Subsidiaries of the Company party thereto, Oramed Pharmaceuticals Inc. and... (Filed With SEC on October 8, 2024)

Rest of World License Term Sheet, dated October 8, 2024, between Oramed Pharmaceuticals, Inc., Scilex Holding Company and the other parties signatories thereto (Filed With SEC on October 8, 2024)

Consent and Side Letter, dated October 2, 2024, by and between Scilex Holding Company and Oramed Pharmaceuticals, Inc (Filed With SEC on October 7, 2024)

Letter Agreement, dated as of September 20, 2024, by and between Oramed Pharmaceuticals Inc. and Scilex Holding Company (Filed With SEC on September 23, 2024)

Satisfaction Agreement, dated as of September 17, 2024, by and among Endeavor Distribution LLC, FSF 33433 LLC and Scilex Holding Company (Filed With SEC on September 18, 2024)

Agreement and Plan of Merger, dated as of August 30, 2024, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc (Filed With SEC on September 3, 2024)

Sponsor Support Agreement, dated as of August 30, 2024, by and among Denali Capital Acquisition Corp. and each of the Persons set forth on Schedule I attached thereto (Filed With SEC on September 3, 2024)

Company Stockholder Support Agreement, dated as of August 30, 2024, by and among Scilex Holding Company, Semnur Pharmaceuticals, Inc. and Denali Capital Acquisition Corp (Filed With SEC on September 3, 2024)

Sponsor Interest Purchase Agreement, dated as of August 30, 2024, by and between Denali Capital Global Investments LLC and Scilex Holding Company (Filed With SEC on September 3, 2024)

Contribution and Satisfaction of Indebtedness Agreement, dated as of August 30, 2024 by and between Scilex Holding Company and Semnur Pharmaceuticals, Inc (Filed With SEC on September 3, 2024)

Stockholder Agreement, dated as of August 30, 2024, by and between Denali Capital Acquisition Corp. and Scilex Holding Company (Filed With SEC on September 3, 2024)

Letter Agreement, dated as of August 30, 2024, by and between Oramed Pharmaceuticals, Inc. and Scilex Holding Company (Filed With SEC on September 3, 2024)

Form of Warrant to Purchase Common Stock (Filed With SEC on June 12, 2024)

Commitment Side Letter, dated June 11, 2024, by and between Scilex Holding Company and FSF 33433 LLC (Filed With SEC on June 12, 2024)

Settlement Agreement, dated February 29, 2024, by and between Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc. and Virpax Pharmaceuticals, Inc (Filed With SEC on May 13, 2024)

Letter Agreement, dated March 14, 2024, by and between Scilex Holding Company and Oramed Pharmaceuticals Inc (Filed With SEC on May 13, 2024)

Form of Common Warrant (Filed With SEC on April 25, 2024)

Form of Placement Agent Warrant (Filed With SEC on April 25, 2024)

Form of Securities Purchase Agreement, dated April 23, 2024, by and between the Company and the purchaser party thereto (Filed With SEC on April 25, 2024)

Description of Securities of Scilex Holding Company (Filed With SEC on March 12, 2024)

Underwriting Agreement, dated February 29, 2024, by and among Scilex Holding Company, Rodman & Renshaw LLC and StockBlock Securities LLC (Filed With SEC on March 5, 2024)

Form of Common Warrant (Filed With SEC on March 5, 2024)

Form of Representative Warrant (Filed With SEC on March 5, 2024)

Settlement Term Sheet, dated February 26, 2024, by and between Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc. and Virpax Pharmaceuticals, Inc (Filed With SEC on February 27, 2024)

Sales Agreement, dated as of December 22, 2023, by and among Scilex Holding Company, B. Riley Securities, Inc., Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (Filed With SEC on December 22, 2023)

Severance and Change of Control Agreement, dated as of November 8, 2023, by and between Jaisim Shah and Scilex Holding Company (Filed With SEC on November 14, 2023)

Severance and Change of Control Agreement, dated as of November 9, 2023, by and between Henry Ji and Scilex Holding Company (Filed With SEC on November 14, 2023)

Severance and Change of Control Agreement, dated as of November 8, 2023, by and between Stephen Ma and Scilex Holding Company (Filed With SEC on November 14, 2023)

Amendment to Convertible Debentures, dated as of October 11, 2023, by and between Scilex Holding Company and YA II PN, Ltd (Filed With SEC on October 11, 2023)

Senior Secured Promissory Note issued to Oramed Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)

Form of Scilex Holding Company Warrant to Purchase Common Stock (Filed With SEC on September 26, 2023)

Securities Purchase Agreement, dated September 21, 2023, by and between Scilex Holding Company, Oramed Pharmaceuticals Inc., and Acquiom Agency Services LLC (Filed With SEC on September 26, 2023)

Registration Rights Agreement, dated September 21, 2023, by and between Scilex Holding Company and Oramed Pharmaceuticals Inc (Filed With SEC on September 26, 2023)

Subsidiary Guarantee, dated September 21, 2023, made by certain of the Companys subsidiaries in favor of the holders of that certain Senior Secured Promissory Note dated as of the... (Filed With SEC on September 26, 2023)

Security Agreement, dated September 21, 2023, by and among Scilex Holding Company, the Subsidiaries of the Company party thereto, Oramed Pharmaceuticals Inc. and Acquiom Agency... (Filed With SEC on September 26, 2023)

Subordination Agreement, dated September 21, 2023, by and among eCapital Health Corp., Scilex Pharmaceuticals Inc. and Acquiom Agency Services LLC (Filed With SEC on September 26, 2023)

Stock Purchase Agreement, dated September 21, 2023, by and between Scilex Holding Company and Sorrento Therapeutics, Inc (Filed With SEC on September 26, 2023)

Assignment, Assumption and Release Agreement, dated September 21, 2023, by and among Scilex Holding Company, Oramed Pharmaceuticals Inc., Sorrento Therapeutics, Inc. and Scintilla... (Filed With SEC on September 26, 2023)

Letter Agreement, dated September 21, 2023, by and among Scilex Holding Company, Sorrento Therapeutics, Inc. and Scintilla Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)

Letter Agreement, dated September 21, 2023, by and between Scilex Holding Company and Sorrento Therapeutics, Inc (Filed With SEC on September 26, 2023)

Consulting Agreement, dated as of September 20, 2023, by and between Scilex Holding Company and Elizabeth Czerepak (Filed With SEC on September 22, 2023)

Settlement Agreement, dated September 15, 2023, by and among Scilex Holding Company, Cove Lane Onshore Fund, LLC, HBC Investments LLC and Hudson Bay Capital Management LP (Filed With SEC on September 21, 2023)

Junior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement, dated as of July 28, 2023, by (Filed With SEC on August 11, 2023)

Form of Underwriting Agreement (Filed With SEC on July 13, 2023)

Debtor-in-Possession Term Loan Facility Summary of Terms and Conditions, dated as of July 5, 2023, between Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc. and Scilex... (Filed With SEC on July 7, 2023)

Intercreditor and Subordination Agreement, dated as of July 5, 2023, by and among JMB Capital Partners Lending, LLC and Scilex Holding Company (Filed With SEC on July 7, 2023)

Amended and Restated Industrial Lease, dated as of April 12, 2023, by and between Scilex Pharmaceuticals, Inc. and 960 San Antonio LLC (Filed With SEC on June 29, 2023)

Credit and Security Agreement, dated as of June 27, 2023, by and between Scilex Pharmaceuticals Inc. and eCapital Healthcare Corp (Filed With SEC on June 27, 2023)

Guaranty Agreement, dated as of June 27, 2023, executed by Scilex Holding Company in favor of eCapital Healthcare Corp (Filed With SEC on June 27, 2023)

Scilex Holding Company 2022 Equity Incentive Plan, as amended (Filed With SEC on May 5, 2023)

Third Convertible Debenture, dated as of April 20, 2023, executed by Scilex Holding Company (Filed With SEC on April 20, 2023)

Second Convertible Debenture, dated as of April 11, 2023, executed by Scilex Holding Company (Filed With SEC on April 11, 2023)

Convertible Debentures, dated as of March 21, 2023, executed by Scilex Holding Company (Filed With SEC on March 21, 2023)

Securities Purchase Agreement, dated as of March 21, 2023, by and between Scilex Holding Company and YA II PN, Ltd (Filed With SEC on March 21, 2023)

Registration Rights Agreement, dated as of March 21, 2023, by and between Scilex Holding Company and YA II PN, Ltd (Filed With SEC on March 21, 2023)

Amended and Restated Standby Equity Purchase Agreement, dated as of February 8, 2023, by and between Scilex Holding Company and YA II PN, LTD (Filed With SEC on February 9, 2023)

Scilex Holding Company 2023 Inducement Plan (Filed With SEC on January 17, 2023)

Form of Stock Option Grant Notice and Stock Option Agreement under the Scilex Holding Company 2023 Inducement Plan (Filed With SEC on January 17, 2023)

Form of Restricted Stock Unit Award Grant Notice and Award Agreement under the Scilex Holding Company 2023 Inducement Plan (Filed With SEC on January 17, 2023)

Standby Equity Purchase Agreement, dated as of January 8, 2023, by and between Scilex Holding Company and B. Riley Principal Capital II, LLC (Filed With SEC on January 9, 2023)

Standby Equity Purchase Agreement, dated as of November 17, 2022, by and between Scilex Holding Company and YA II PN, LTD (Filed With SEC on November 18, 2022)

Amended and Restated Registration Rights Agreement, dated as of November 10, 2022, by and among Scilex Holding Company, Vickers Venture Fund VI Pte Ltd, Vickers Venture Fund VI... (Filed With SEC on November 17, 2022)

Form of Indemnification Agreement of Scilex Holding Company (Filed With SEC on November 17, 2022)

Scilex Holding Company 2022 Equity Incentive Plan (Filed With SEC on November 17, 2022)

Form of Stock Option Grant Notice and Stock Option Agreement under the Scilex Holding Company 2022 Equity Incentive Plan (Filed With SEC on November 17, 2022)

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Scilex Holding Company 2022 Equity Incentive Plan (Filed With SEC on November 17, 2022)

Scilex Holding Company 2022 Employee Stock Purchase Plan (Filed With SEC on November 17, 2022)

Debt Contribution Agreement, dated as of October 17, 2022, by and among Vickers Vantage Corp. I, Vickers Venture Fund VI (Plan) Pte Ltd and Vickers Venture Fund VI Pte Ltd (Filed With SEC on October 18, 2022)

Amendment No. 1 to Agreement and Plan of Merger, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Vantage Merger Sub Inc. and Scilex Holding Company (Filed With SEC on September 14, 2022)

Stockholder Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc. and Vickers Vantage Corp. I (Filed With SEC on September 14, 2022)

Amendment No. 1 to Sponsor Support Agreement, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Scilex Holding Company and each of the Persons set forth on... (Filed With SEC on September 14, 2022)

Promissory Note (Filed With SEC on April 11, 2022)

Amendment to Underwriting Agreement dated as of March 17, 2022 by and among Maxim Group LLC as representative of the underwriters named on Schedule A of the Agreement, and Vickers... (Filed With SEC on March 21, 2022)

Form of Promissory Note (Filed With SEC on January 7, 2022)

Description of the Registrants Securities (Filed With SEC on March 31, 2021)

Underwriting Agreement between the Company and Maxim Group LLC, as representative of the underwriters (Filed With SEC on January 11, 2021)

Warrant Agreement between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on January 11, 2021)

Investment Management Trust Agreement between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on January 11, 2021)

Registration Rights Agreement between the Company and certain security holders (Filed With SEC on January 11, 2021)

Administrative Services Agreement (Filed With SEC on January 11, 2021)

Form of Indemnification Agreement (Filed With SEC on January 11, 2021)

Form of Underwriting Agreement (Filed With SEC on December 28, 2020)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 28, 2020)

Specimen Unit Certificate (Filed With SEC on December 15, 2020)

Specimen Ordinary Shares Certificate (Filed With SEC on December 15, 2020)

Specimen Warrant Certificate (Filed With SEC on December 15, 2020)

Form of Warrant Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on December 15, 2020)

Form of Letter Agreement among the Registrant and each of the sponsors, directors and officers of the Registrant (Filed With SEC on December 15, 2020)

Form of Investment Management Trust Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on December 15, 2020)

Form of Registration Rights Agreement between the Registrant and securityholders (Filed With SEC on December 15, 2020)

Form of Indemnity Agreement (Filed With SEC on December 15, 2020)

Form of Administrative Services Agreement (Filed With SEC on December 15, 2020)

Form of Subscription Agreement (Filed With SEC on December 15, 2020)

Category

Industry

Companies

Contracts

Vickers Vantage Corp. I Contracts & Agreements